Rezivertinib
Product Specifications
CAS Number
1835667-12-3
Synonyms
BPI-7711
Target
EGFR
Applications
Protein Tyrosine Kinase
Molecular Formula
C27H30N6O3
Additionnal Information
Rezivertinib (BPI-7711) is a potent third-generation inhibitor of EGFR tyrosine kinase, targeting both EGFR-sensitizing mutations and the EGFR T790M mutation. Additionally, it has excellent CNS penetration and has antitumor activity.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
135146 100 µg
USP10 (Ubiquitin-specific-processing Protease 10, Ubiquitin Carboxyl-terminal Hydrolase 10, Deubiquitinating Enzyme 10, Ubiquitin Thioesterase 10, KIAA0190, UBPO)
Sign In for Pricing
View Details 